About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $4.05 (-1.94%)
CRBP NASDAQ Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
$4.050
Change (24hr)
-0.08 USD (1.94%)
Volume
372.42K
Volume (4w avg)
-
Open
$4.08
Day Range
$3.93 - $4.08
Previous Close
$4.13
Last Trade
23 Oct, 8:00 pm GMT+0
Delayed
23 Oct, 8:00 pm GMT+0
CRBP price performance
Delayed
23 Oct, 8:00 pm GMT+0
CRBP Market Signals